• Phase I – 2021 – Preparation of 3D composite scaffolds
  • Phase II – 2022 – Incorporation of bioactive principles in the structure of 3D composite scaffolds and evaluation of their cytocompatibility in vitro. Obtaining of an osteoporosis model in vivo.
  • Phase III – 2023 – In vivo evaluation of the osteogenic potential of the 3D composite scaffolds.